TELA Bio, Inc. (NASDAQ: TELA) reported Q3 EPS of ($0.64), $0.02 worse than the analyst estimate of ($0.62). Revenue for the quarter came in at $11.2 million versus the consensus estimate of $10.86 million.

For earnings history and earnings-related data on TELA Bio, Inc. (TELA) click here.